ArticleInvestigational new drugs2023

Efficacy, safety, and cost-minimization analysis of axicabtagene ciloleucel and tisagenlecleucel CAR T-Cell therapies for treatment of relapsed or refractory follicular lymphoma.

Buthainah GhanemPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.